Phase 2/3 Study of Oral Rigosertib and Injectable Azacitidine versus Injectable Azacitidine in Treatment-Naïve Patients with Higher-Risk MDS

Download Transcript Download Audio

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com